Symbollon Pharmaceuticals to launch IoGen women's breast health dietary supplement in February

Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) (www.symbollon.com) has announced today that the retail launch of IoGen™, its dietary supplement for women's breast health, will commence in February. IoGen™ is the first dietary supplement formulated to promote breast health for women. Initially, the Company plans to market IoGen™ through its own retail web site, which is currently being developed by Atech Solutions. This rapid launch schedule was made possible when the Company reacquired the significant IoGen™ finished goods inventory previously purchased by its former distributor. In preparation of the launch, Symbollon has partnered with ProLog Logistics (www.prologlogistics.com), a state-of-the-art fulfillment center with a complete customer service support division.

"We are moving very quickly to prepare the IoGen™ product launch," stated Paul C. Desjourdy, President and Chief Executive Officer of Symbollon. "We recently repurchased the IoGen finished goods inventory from our previous distributor. This significant inventory will advance our expected retail launch of IoGen™ by months. By partnering with Atech Solutions for the web site development and ProLog Logistics for complete state-of-the-art fulfillment and customer service needs, we believe that we will provide women looking to improve their breast health with a responsive and customer focused buying experience. Making this important female health product available to women is an important first step in helping improve the lives of millions of women concerned with their overall breast health."